RANDOLPH, N.J., Aug. 29, 2017 /PRNewswire/ -- In a move that promises to exponentially enhance drug inventory management, security, and regulatory compliance for veterinary practices of all sizes, Cubex LLC and The TITAN Group today announced a new partnership that makes TITAN's expertise in physical security, drug diversion investigations, staff training, and legal compliance available to Cubex's clients nationally.
"Every veterinary practice and healthcare provider buying and handling controlled substances is at risk today," said TITAN founder and CEO, Jack Teitelman. "In the current world of widespread opioid abuse, many unsuspecting providers remain in the dark until their drugs are stolen or missing. Thanks to Cubex, TITAN will now be there to help shine a light on vulnerabilities." Teitelman, a former DEA Supervisory Special Agent with nearly three decades of experience investigating drug-related crimes, pointed out that inadequate security and failure to prevent drug diversion can cost a practice in lost inventory, damage to reputation, and potential physical harm to staff and patients.
Teitelman went on to explain that the opioid abuse crisis has also led to increased scrutiny by government regulatory agencies. DEA, for example, can seek fines of $14,502 per incident for inadequate record keeping of controlled substance records, lack of physical security and minimal or poor onboarding background procedures. Cubex solutions provide both the required security for keeping controlled substances secure as well as real-time, automated drug logs and will now facilitate access to TITAN's services helping veterinary practices improve compliance and prepare for future audits and inspections.
The Cubex/TITAN partnership will create a bundle of physical security assessments, compliance audits, and staff training services available to all Cubex customers through special pricing and incentives. Cubex sees this new partnership as a way to give its customers additional value and enhanced peace of mind. "Inventory management and inventory security is an often overlooked yet very significant expenditure for veterinary hospitals," said Cubex President and CEO, Anton Visser. "The ability to help our customers optimize inventory efficiencies while adding an extra layer of protection is huge."
Veterinary practices interested in learning about the partnership's services can contact The TITAN GROUP at 347-723-8019 or meet with TITAN representatives at the Cubex exhibit in Booth 1027 during the 2017 International Veterinary Emergency and Critical Care Symposium ("IVECCS"), September 13-17, at the Gaylord Opryland Resort & Convention Center, Nashville, TN.
ABOUT TITAN: Founded by retired DEA Supervisory Special Agent, Jack Teitelman, The TITAN Group is a full-service regulatory compliance, drug security and anti-diversion solutions provider. TITAN's team of experts service veterinary practices, clinics, and other healthcare clients using more than three decades of law enforcement, security and private industry experience. TITAN's services are designed to identify and mitigate risks via improved physical security, staff education, recordkeeping audits, and operational assessments. The TITAN Group's suite of services are found at www.titandrugdiversion.com
ABOUT CUBEX®: Cubex® is a global provider of health care products and services that helps practices measurably reduce the total cost of ownership associated with pharmacy and supplies. The company develops market-leading technologies including Cubex SupplyBank automated dispensing systems, Cubex MedFlex and MedBank narcotic management stations, QBud wireless access devices, and the Cubex cloud-based software and business intelligence application. For more information on Cubex products and services, visit www.cubex.biz.